Article3 Biotech2019

An oncoinformatics study to predict the inhibitory potential of recent FDA-approved anti-cancer drugs against human Polo-like kinase 1 enzyme: a step towards dual-target cancer medication.

Syed Mohd Danish Rizvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.